[Apropos of certain toxic effects of L-asparaginase in human therapy].
D000208:Acute Disease; D000328:Adult; D000641:Ammonia / Q000097:blood; D001215:Asparaginase / Q000009:adverse effects*; D001247:Asthenia / Q000139:chemically induced; D001778:Blood Coagulation Disorders / Q000139:chemically induced; D001921:Brain / Q000187:drug effects; D056486:Chemical and Drug Induced Liver Injury; D002648:Child; D004569:Electroencephalography; D006461:Hemolysis; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D013924:Thrombophlebitis / Q000139:chemically induced; D014474:Unconsciousness / Q000139:chemically induced
D000641:Ammonia; D001215:Asparaginase
A propos de certains effets toxiques de la L-asparaginase en thérapeutique humaine.